Gene Therapy for ADA-SCID Using an Improved Lentiviral Vector (Ivlv-ADA)
Clinical trial NCT03645460 · RECRUITING
Trial details
- NCT number
- NCT03645460
- Sponsor
- Shenzhen Geno-Immune Medical Institute
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-30
- Primary completion
- 2026-12-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.